MyoKardia announces receipt of milestone payment from Sanofi for DCM candidate MYK-491
MyoKardia announced the Company has received a $25 million milestone payment in accordance with the research agreement between MyoKardia and Sanofi established in August 2014 for the filing of an IND application with the FDA for MYK-491 in dilated cardiomyopathy. December 02, 2016